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New variants of GCaMP-type genetically encoded Ca2+ indicators (GECIs) have been
continuously developed and heavily used in many areas of biology including neuroscience.
The latest subfamily called “GECOs” were developed with in vitro high-throughput
screening, and shown to have novel spectral properties and/or improved fluorescent
responses over their ancestor GCaMP3. The most critical parameter in evaluating
performance in neurons, however, remains uncharacterized: the relationship between the
GECI responses and the number of action potentials (APs). Here we analyzed the GECI
responses to APs in cortical pyramidal cells of mouse acute brain slices. Unexpectedly,
we found that none of the GECOs exhibited any improved performance over GCaMP3.
Our results imply that careful validation is required for the accurate prediction of the actual
performance of GECIs in mammalian neurons. We propose that appropriate guidelines
for evaluating their efficacy should be established for the benefit of research community,
given the rapidly expanding use of GECIs in neuroscience.
Keywords: genetically encoded Ca2+ indicators, GCaMP, GECO, two-photon imaging, patch-clamp recording,
cortical pyramidal cell, in utero electroporation, acute brain slice
INTRODUCTION
Genetically encoded Ca2+ indicators (GECIs; for review: Mank
and Griesbeck, 2008; Tian et al., 2012), or Ca2+-sensitive fluores-
cent proteins, are regarded as promising tools for many areas of
biology including neuroscience. Since GECIs can in principle be
stably expressed in a targeted type of cells, they emerged as crit-
ically important tools for analyzing long-term changes of in vivo
multi-neuronal activity during learning, development and disease
(Mank et al., 2008; Huber et al., 2012).
Among several types of GECIs, GCaMP family (Nakai et al.,
2001) has attracted intense attention in the field. It consists
of circularly-permutated GFP, calmodulin (CaM), and M13
(Ca2+/CaM-binding peptide derived from skeletal musclemyosin
light chain kinase), and changes its fluorescence intensity in
response to [Ca2+]i changes. The first prototypes suffered from
poor expression at mammalian physiological temperature (Nakai
et al., 2001; Ohkura et al., 2005), but this problem was over-
come by subsequent mutagenesis, resulting in GCaMP2 (Tallini
et al., 2006). GCaMP2 was successfully used to monitor activa-
tion of cerebellar parallel fibers (Díez-García et al., 2005, 2007)
and vomeronasal neurons (He et al., 2008), yet it turned out to be
mostly insensitive to [Ca2+]i changes caused by single or small
number of action potentials (APs) (Mao et al., 2008). Taking
advantage of the crystal structure information described (Wang
et al., 2008; Akerboom et al., 2009), GCaMP2 was mutagenized
into GCaMP3 to show higher baseline fluorescence and larger
dynamic range (Tian et al., 2009). Although GCaMP3 has been
widely used for recording in vivo activity of mammalian neurons
(Dombeck et al., 2010; Huber et al., 2012; Keller et al., 2012),
its detection reliability of single APs is still relatively low under
physiological conditions (Tian et al., 2009; Yamada et al., 2011).
This issue makes it difficult to relate the fluorescent responses
with neuronal activity, and thus should be overcome in the next
generation of GCaMP.
The most recent subfamily of GCaMPwas developed with ran-
dom mutagenesis of GCaMP3 accompanied by high-throughput
in vitro screening (Zhao et al., 2011). The best variants with
improved performance and/or novel spectral properties were
efficiently selected from >105 clones, and termed genetically
encoded Ca2+ indicators for optical imaging (GECOs). The supe-
rior functionality of GECOs was confirmed by Ca2+ titration
with purified proteins and live imaging of cancer cell line. All
of the three variants of green GECOs (G-GECOs) with differ-
ent dissociation constants (Kd) for Ca2+ (G-GECO1.0, 750 nM;
G-GECO1.1, 620 nM; and G-GECO1.2, 1150 nM) showed twice
as large dynamic range as GCaMP3 (Kd : 540 nM). Red-shifted
GECO (R-GECO1; Kd: 480 nM) showed dynamic range simi-
lar to GCaMP3. Blue-green emission ratiometric GECO (GEM-
GECO1; Kd: 340 nM) showed the largest dynamic range, 6–9-fold
larger than GCaMP3. Furthermore, G-GECOs were shown to be
superior to, and R-GECO1 comparable to, GCaMP3 in detecting
spontaneous activity of cultured rat hippocampal neurons, and
GEM-GECO1 was shown to be functional in sensory neurons of
C. elegans.
Nevertheless, the most critical parameter of GECOs for
evaluating their performance in neurons remains poorly char-
acterized: the relationship between fluorescent responses and
the number of APs. This leaves open the possibility that the
GECO-expressing neurons happened to be more actively fir-
ing than GCaMP3-expressing neurons, resulting in apparently
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improved performance. In addition, most data in the original
study were acquired in a culture system, where GECIs sometimes
show larger responses compared to non-culture or in vivo sys-
tems (Tian et al., 2009). It therefore remains unclear whether
GECOs can indeed show improved performance in mammalian
neurons.
To address these issues, we analyzed the GECI responses to APs
in cortical pyramidal cells of mouse acute brain slices by simul-
taneous two-photon imaging and patch-clamp recording, and
investigated whether GECOs would indeed show better responses
than their ancestor GCaMP3.
MATERIALS AND METHODS
All experimental procedures were performed in accordance with
the guidelines of the Animal Experiment Committee of the
RIKEN Brain Science Institute.
In utero ELECTROPORATION
cDNAs encoding GCaMP3, G-GECO1.0, G-GECO1.1, G-
GECO1.2, R-GECO1, and GEM-GECO1 were subcloned into
a plasmid vector carrying the cytomegalovirus enhancer and
β-actin (CAG) promoter, woodchuck hepatitis virus post-
transcriptional regulatory element (WPRE) and bovine growth
hormone (BGH) polyadenylation signal (Gray et al., 2006).
To facilitate identification of mice or cells expressing GECIs,
tdTomato (Shaner et al., 2004) was co-expressed with GCaMP3
and G-GECOs, and EGFP with R-GECO1 by internal ribo-
some entry site (IRES). All constructs were verified by DNA
sequencing. In utero electroporation was performed as pre-
viously described (Saito, 2006; Shimogori and Ogawa, 2008).
Briefly, embryonic day (E) 15 timed-pregnant ICR mice (Japan
SLC) were anesthetized by intraperitoneal injection of sodium
pentobarbital (approximately 50mg/kg) and uterus horns were
exposed on a heating pad (BWT-100, BRC). Approximately 1μl
of purified plasmid solution (1μg/μl in phosphate buffer solu-
tion (PBS), with 0.02% Fast Green) was pressure-injected (IM-
300, Narishige) into the lateral ventricle of embryos, and five
electrical pulses (45V, 50ms duration at 1Hz) were delivered
through the uterine wall by a tweezer-type electrode (CUY650-
P5, NEPA GENE) connected to an electroporator (CUY21-EDIT,
NEPA GENE). After electroporation, the embryos were carefully
replaced into the abdominal cavity, and the muscle and skin were
sutured.
ELECTROPHYSIOLOGY AND TWO-PHOTON IMAGING IN ACUTE
BRAIN SLICE
Parasagittal cortical slices (300μm) were prepared using a
vibratome (VT1000S, Leica) from electroporated mice on post-
natal day (P) 14–25, as described previously (Davie et al., 2006).
Brain dissection and slice preparation were performed in ice-
cold cutting solution containing 87mM NaCl, 75mM sucrose,
2.5mM KCl, 0.5mM CaCl2, 7mM MgCl2, 1.25mM NaH2PO4,
25mM NaHCO3, 10mM D-glucose (320–330mOsm/kg) and
transferred to artificial cerebral spinal fluid (ACSF) contain-
ing 125mM NaCl, 2.5mM KCl, 2mM CaCl2, and 1mM
MgCl2, 1.25mM NaH2PO4, 25mM NaHCO3, 25mM D-glucose
(310–320mmol/kg), incubated at 34◦C for 30–60min and
preserved at room temperature until use. Both cutting solution
and ACSF were saturated with carbogen. Slices were perfused
with ACSF warmed up to 33 ± 2◦C by an in-line heater (TC-
324B, Warner Instruments) at approximately 2ml/min. GECI-
expressing cortical layer 2/3 pyramidal cells were identified
by epifluorescence and targeted for whole-cell patch-clamp
recording under infra-red differential interference contrast
microscopy (IR-DIC; Olympus). Electrophysiological signals
were low-pass filtered at 3–10 kHz by 4-pole Bessel filter and
acquired at 20–50 kHz using MultiClamp 700B (Molecular
Devices) connected to ITC-16, ITC-18 (Instrutech) or Digidata
1440 (Molecular Devices) controlled by AxoGraphX (AxoGraph
Scientific) or pClamp10 (Molecular Devices). Boroscilicate glass
pipettes (4–7M) were filled with the internal solution contain-
ing 140mMK-gluconate, 4mMNaCl, 10mMHEPES, 4mMMg-
ATP, 0.3mM Na-GTP and 5mM Na2-phosphocreatine (pH 7.3
titrated with KOH, 285–295mmol/kg). In experiments using
Oregon Green 488 BAPTA-1 (OGB-1; Invitrogen), slices were
prepared from non-electroporated mice, and 20μM OGB-1
and 25μM Alexa Fluor 594 (Invitrogen) was added to the
pipette solution. APs were evoked by brief somatic current pulses
(1–3 nA, 2ms) delivered through recording patch pipettes.
For experiments with GECIs, image acquisition began typi-
cally after 2min of break-in and terminated within 30min given
washout of GECIs (Pologruto et al., 2004; Mao et al., 2008). For
experiments with OGB-1, image acquisition began after 15min
of break-in for equilibration of the dyes.
Fluorescent signals were acquired in line-scan mode (approx-
imately 200Hz) with an upright two-photon laser-scanning
microscope (BX-61WI with FV300 or FV1000-MPE, Olympus)
equipped with a 60×water-immersion objective (LUMPlan Fl/IR
NA 0.90, Olympus). Imaging was performed across the proximal
apical dendritic segments (<30μm from the base) as described
previously (Pologruto et al., 2004; Mao et al., 2008; Tian et al.,
2009; Yamada et al., 2011). The Ti:sapphire laser (Maitai VF-
TIM or Maitai DeepSee, Spectra-Physics) was tuned to 920 nm
for GCaMP3 and G-GECOs, 990 nm for R-GECO1, 780 nm
for GEM-GECO1 or 800 nm for OGB-1. Emitted fluorescence
was short-pass filtered (650 or 690 nm, Olympus), split with a
dichroic mirror, band-pass filtered and detected by photomulti-
pliers (R3896, Hamamatsu). Details of optical filters are provided
in Table 1.
The electrophysiological recording and 2-photon imaging
were synchronized by a trigger pulse generated upon laser
scanning.
Table 1 | Summary of optical filters (all from Olympus).
GECIs Optical filters
GCaMP3, G-GECOs, OGB-1 DM: 570nm
Em: 495–540nm
R-GECO1 DM: 570nm
Em: 575–630nm
GEM-GECO1 DM: 485nm
Em: 420–460nm (“blue”),
495–540nm (“green”)
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DATA ANALYSIS
After subtraction of dark noise on the photomultipliers, the mean
baseline fluorescence (F0, GCaMP3, G-GECOs, R-GECO1, and
OGB-1) or the mean baseline ratio of blue to green fluores-
cence (R0, GEM-GECO1) was calculated as the mean fluores-
cence or the mean ratio, respectively, of the approximately 1 s
window immediately before stimulus onset (baseline period).
Subsequently, the fractional change of the fluorescence (F/F0,
GCaMP3, G-GECOs, R-GECO1, and OGB-1) or the frac-
tional change of the ratio (R/R0, GEM-GECO1) was cal-
culated. To facilitate comparison across GECIs with different
baseline noise level, the signal-to-noise ratio (SNR) was cal-
culated as F/F0 or R/R0 divided by the baseline standard
deviation. Peak SNR was calculated from SNR trace filtered
with a 35ms moving window and defined as the maximum
value between the stimulus onset and 500ms after the stimulus
A B
D
F
E
C
0
0.2
0.4
0.6
0.8
1.0
1.2
GC3 1.0 1.1 1.2
N
or
m
al
iz
ed
 b
as
al
 fl
uo
re
sc
en
ce * ******
G
GCaMP3 G-GECO1.0
G-GECO1.1 G-GECO1.2
R-GECO1
GEM-GECO1
FIGURE 1 | Expression patterns of GCaMP3 and GECOs in cortical layer
2/3 pyramidal cells. (A–D) Representative expression patterns of GCaMP3
(A) G-GECO1.0 (B) G-GECO1.1 (C) G-GECO1.2 (D). Maximum intensity
projection images (left) and single z-section images containing the nucleus
(right) of GECIs are shown. (E) A representative expression pattern of
GEM-GECO1. A maximum intensity projection image of the blue channel
(left) and a maximum intensity projection image of the green channel (center)
and a single z-section of the green channel containing the nucleus (right) are
shown. (F) A representative expression pattern of R-GECO1. A maximum
intensity projection image (left) and a single z-section containing the nucleus
(right) of R-GECO1 are shown. Punctate structures are indicated by
arrowheads. Image contrast was adjusted to clarify the presence or absence
of nuclear fluorescence. Scale bar represents 10μm. (G) The mean baseline
fluorescence intensity of GCaMP3 and G-GECOs normalized by the
fluorescence intensity of co-expressed tdTomato (n = 13 for GCaMP3,
n = 10 for G-GECO1.0 and G-GECO1.1, and n = 9 for G-GECO1.2). Significant
difference in Dunn’s post-hoc test comparing GCaMP3-expressing cells and
GECO-expressing cells: ∗p < 0.05, ∗∗∗p < 0.001.
Frontiers in Cellular Neuroscience www.frontiersin.org October 2012 | Volume 6 | Article 41 | 3
Yamada and Mikoshiba GECOs in mouse brain slice
cessation. SNR was calculated from individual trials and aver-
aged over 3 trials for each stimulus condition. Responses were
judged to be suprathreshold when SNR exceeds 2. Half rise
time and half decay time were calculated from the 3-trial-
averaged and filtered traces for 10 APs only when responses
were suprathreshold. Statistical difference was assessed using
Kruskal–Wallis test (p = 0.05) followed by Dunn’s post-hoc
test to compare GCaMP3 and one of the GECOs individu-
ally, unless otherwise noted. Data analysis was performed with
AxoGraphX, Igor Pro 6 (WaveMetrics), NeuroMatic (http://www.
neuromatic.thinkrandom.com/), Fluoview (Olympus), ImageJ
(US National Institutes of Health), Excel (Microsoft) and
GraphPad Prism4 (GraphPad software). All values are presented
as mean ± standard deviation and error bars show standard
deviation.
RESULTS
THE EXPRESSION PATTERN OF GCaMP3 AND GECOs
We expressed GCaMP3 and GECOs in mouse cortical layer
2/3 pyramidal cells by in utero electroporation. GCaMP3,
G-GECOs and GEM-GECO1 were expressed normally in the
cytosol, with majority of cells lacking fluorescence in the nucleus
(Figures 1A–E). In contrast, R-GECO1 was typically expressed
in the nucleus as well as the cytosol, where it showed punctate
structures (Figure 1F). This is reminiscent of other coral-derived
fluorescence proteins that are resistant to proteolysis in acidic
organella (Hirrlinger et al., 2005; Katayama et al., 2008, 2011;
Perron et al., 2009).
G-GECOs had much lower basal fluorescence than GCaMP3
(Figure 1G; normalized fluorescence intensity of GCaMP3,
0.79 ± 0.15, n = 13; G-GECO1.0, 0.25 ± 0.05, n = 10, p < 0.05;
G-GECO1.1, 0.15 ± 0.03, n = 10, p < 0.001; G-GECO1.2,
0.17 ± 0.03, n = 9, p < 0.001), which could be a significant
disadvantage for in vivo application.
THE PERFORMANCE OF GCaMP3 AND GECOs IN CORTICAL LAYER 2/3
PYRAMIDAL CELLS
We characterized the performance of GECIs expressed in the
cortical layer 2/3 pyramidal cells by simultaneous 2-photon
imaging and whole-cell patch-clamp recording in acute brain
slice preparations. Overall, the expression of GECIs did not have
significant effects on the electrophysiological properties of pyra-
midal cells, except G-GECO1.0 and GEM-GECO1, the expression
of which seemed to result in higher threshold and broader half
width of APs (Table 2).
We evoked APs by somatic current injection and recorded
fluorescent changes by line-scan imaging at apical dendritic seg-
ments (<30μm from the base). Responses to 1, 2, 5, 10, and
20 APs at 20Hz and 40APs at 83Hz were analyzed (Figures 2, 3
and Table 3). Unexpectedly, we found that none of the GECOs
showed any improved performance over GCaMP3. Compared
to GCaMP3: G-GECO1.0 was not significantly different over
the entire stimulus range tested; G-GECO1.1 showed the same
trend, except for smaller responses to 40APs; G-GECO1.2 showed
smaller responses over the entire stimulus range tested except
for 1 AP and 40APs; R-GECO1 showed smaller responses over
the entire stimulus range tested except for 1 AP; and GEM-
GECO1 showed significantly smaller responses over the entire
stimulus range tested. Furthermore, G-GECOs showed slightly
yet significantly slower half rise time (Figure 4A; GCaMP3, 236
± 41ms, n = 13; G-GECO1.0, 280 ± 106ms, n = 9, p < 0.05;
G-GECO1.1, 282 ± 30ms, n = 10, p < 0.01; G-GECO1.2, 257
± 28ms, n = 9, p > 0.05; R-GECO1, 213 ± 65ms, n = 7, p >
0.05) and half decay time (Figure 4B; GCaMP3, 190 ± 37ms,
n = 13; G-GECO1.0, 260 ± 59ms, n = 9, p < 0.05; G-GECO1.1,
301 ± 85ms, n = 10, p < 0.001; G-GECO1.2, 249 ± 83ms, n =
9, p < 0.05; R-GECO1, 228 ± 73ms, n = 7, p > 0.05).
COMPARISON WITH OGB-1
In order to clarify the factors to be improved in the next gener-
ation of GCaMP, we quantified the performance of OGB-1, one
of the most commonly used synthetic dyes for in vivo imaging.
We loaded OGB-1 through recording patch pipettes at 20μM,
which is close to the concentration obtained by the bolus loading
technique (Stosiek et al., 2003). Consistent with previous studies
(Waters et al., 2003; Kerr et al., 2005), OGB-1 reliably detected
single APs (Figures 2, 3 and Table 4). Responses of OGB-1 to
1, 2, and 5APs at 20Hz were significantly larger than those of
Table 2 | Electrophysiological properties of layer 2/3 pyramidal cells expressing GCaMP3 and GECOs.
Ephys GC3 (n = 13) 1.0 (n = 10) 1.1 (n = 10) 1.2 (n = 9) R (n = 9) GEM (n = 9) no exp (n = 11)
Vm a −80±5.8 −81±4.8 −82±5.6 −82±4.1 −78±2.1 −80± 3.8 −82± 8.7
Rm b 135±32 107±44 124±54 134±66 128±25 113± 31 139± 42
AP amplitude c 100±6.8 98±9.2 103±8.1 101±8.0 105±7.1 100± 4.9 107± 19
AP threshold d −43±5.5 −41±5.1* −45±3.6 −42±3.7 −43±7.7 −37± 5.5*** −47± 7.4
AP half width e 2.0±0.8 2.8±1.1** 2.0±0.6 2.1±0.6 2.2±1.4 4.2± 2.7*** 1.7± 0.5
All values are corrected for liquid junction potential (12 mV). Significant difference in Dunn’s post-hoc test comparing GECI-expressing cells and wild-type cells:
*p < 0.05; **p < 0.01; ***p < 0.001. GC3, GCaMP3; 1.0, G-GECO1.0; 1.1, G-GECO1.1; 1.2, G-GECO1.2; R, R-GECO1; GEM, GEM-GECO1; no exp, cells from wild-
type animals without OGB-1.
aResting membrane potential (mV).
bInput resistance (M).
cAmplitude of action potential measured from the resting membrane potential (mV).
d Threshold voltage for action potential generation defined as the point where the first temporal derivative of the voltage first exceeds 50 mV/ms (mV).
eFull width of action potential measured at half the amplitude (ms).
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FIGURE 2 | Action potential-evoked responses of GCaMP3, GECOs, and
OGB-1 in cortical layer 2/3 pyramidal cells. (A) SNR traces in response to
1 (black), 2 (blue), 5 (green), 10 (orange) and 20 (red) action potentials (APs)
evoked at 20Hz. Each trace is the mean across cells (n = 13 for GCaMP3,
n = 10 for G-GECO1.0 and G-GECO1.1, n = 9 for G-GECO1.2, R-GECO1 and
GEM-GECO1, and n = 8 for OGB-1). (B) Peak SNR of GECI responses plotted
against the number of APs evoked at 20Hz. Gray represents data from
individual cells and black the mean across cells.
GCaMP3. OGB-1 responses showed saturation in response to
large number of APs (10 and 20APs; Figure 2B) as described pre-
viously (Yasuda et al., 2004). Responses of OGB-1 to 40APs were
indeed significantly smaller than those of GCaMP3 (Figure 3A
and Table 4). Half rise time of OGB-1 was significantly faster than
that of GCaMP3 (OGB-1, 26 ± 16ms, n = 8; GCaMP3, 236 ±
41ms, n = 13; p < 0.001, Mann–Whitney U test), while half
decay time was not significantly different (OGB-1, 215 ± 108ms,
n = 8; GCaMP3, 190 ± 37ms, n = 13; p = 0.86, Mann–Whitney
U test).
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FIGURE 3 | Responses of GCaMP3, GECOs, and OGB-1 to 40 APs evoked
at 83Hz. (A) SNR traces in response to 40APs evoked at 83Hz. Gray traces
are from individual cells and black traces represent the mean across cells
(n = 8 for GCaMP3, R-GECO1, and OGB-1, n = 7 for G-GECO1.0, and n = 9
for G-GECO1.1, G-GECO1.2 and GEM-GECO1). (B) The mean peak SNR for
40 APs evoked at 83Hz. Significant difference in Dunn’s post-hoc test
comparing GCaMP3-expressing cells and GECO-expressing cells: ∗p < 0.05,
∗∗∗p < 0.001.
Table 3 | SNR of GCaMP3 and GECOs in cortical layer 2/3 pyramidal cells.
Number of APs GC3 (n = 13) 1.0 (n = 10) 1.1 (n = 10) 1.2 (n = 9) R (n = 9) GEM (n = 9)
1 1.5±0.8 1.4±0.2 1.2±0.4 1.1±0.2 1.4±0.9 0.9±0.1**
2 2.5±1.6 2.4±1.6 1.7±0.5 1.4±0.4* 1.6±0.9* 1.0±0.2***
5 7.2±6.0 4.8±3.2 4.1±1.8 2.8±1.2* 2.4±1.1** 1.4±0.3***
10 15±12 8.3±5.5 9.0±4.9 5.8±2.9* 3.2±1.2*** 2.1±0.8***
20 27±22 15±12 17±9.2 10±6.5* 4.8±2.1*** 3.4±1.0***
40 157±39 103±70 59±12* 73±39 11±3.1*** 11±3.2***
Action potentials (APs) were evoked at 20 Hz except for 40 APs evoked at 83 Hz. The numbers of recorded cells in the table apply to 1–20 APs; for 40 APs, n = 8
for GCaMP3 and R-GECO1, n = 7 for G-GECO1.0, and n = 9 for G-GECO1.1, G-GECO1.2 and GEM-GECO1. Significant difference in Dunn’s post-hoc test comparing
GCaMP3-expressing cells and GECO-expressing cells: *p < 0.05, **p < 0.01, ***p < 0.001.
DISCUSSION
In the present study, we found that the latest variants of
GCaMP or GECOs did not exhibit any improved responses
over their ancestor GCaMP3: G-GECOs had lower baseline flu-
orescence, similar or smaller dynamic range, and slower rise
and decay kinetics; R-GECO1 showed expression invading the
nucleus and punctate patterns in the cytosol, and had much
smaller dynamic range; GEM-GECO1 also had much smaller
dynamic range.
VALIDITY OF THE TECHNIQUES USED IN THE PRESENT STUDY
The present study was designed to be optimal for efficient com-
parison across many GECI constructs as well as to be extendable
to future in vivo experiments.
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FIGURE 4 | Kinetics of GCaMP3 and GECOs in cortical layer 2/3
pyramidal cells. (A,B) The mean half rise time (A) and mean half decay
time (B) of smoothed trial-averaged traces in response to 10APs at 20Hz
(n = 13 for GCaMP3, n = 9 for G-GECO1.0 and G-GECO1.2, n = 10 for
G-GECO1.1, and n = 7 for R-GECO1). GEM-GECO1 was excluded from
analysis due to the small number of cells showing suprathreshold
responses (n = 4). Significant difference in Dunn’s post-hoc test comparing
GCaMP3-expressing cells and GECO-expressing cells: ∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001.
Table 4 | SNR of OGB-1 in cortical layer 2/3 pyramidal cells.
Number of APs OGB-1 (n = 8)
1 6.7±2.1***
2 8.7±2.4***
5 10±2.8*
10 12±3.3
20 13±3.8
40 17±4.3***
Action potentials (APs) were evoked at 20 Hz except for 40 APs evoked at 83 Hz.
Statistical difference between OGB-1 and GCaMP3 was assessed by Mann–
Whitney U test: *p < 0.05, ***p < 0.001.
Ideally, the characterization of all the GECIs should be per-
formed in vivo, yet this is not practical for comparison across
many constructs. We believe that characterization of GECIs
in acute brain slices at physiological temperature should be a
reasonable compromise, as it not only gives a good yield of data
but also seems to predict in vivo GECI performance more reliably
than other in vitro preparations (Tian et al., 2009; also see the next
section).
Compared to other techniques applicable for acute brain
slice preparation (virus and transgenic animals), in utero elec-
troporation should be preferable for early screening of many
constructs, as it is faster and less laborious, only requiring
a purified plasmid and pregnant mice for each new con-
struct. One concern may be that Ca2+ buffering by GECI
expression during the development might perturb the prop-
erties of neurons, but the electrophysiological parameters of
GECI-expressing neurons were overall not significantly dif-
ferent from those of wild-type cells. It would be interesting
to test in the future whether (1) the functionality of GECIs
remain comparable when they are expressed for a longer
period of time (Mank et al., 2008; Tian et al., 2009; Yamada
et al., 2011) and (2) different transfection methods (virus and
transgenic animals) can result in different GECI performance,
especially when more promising GECIs are developed and vali-
dated.
Imaging in this study was performed exclusively at the proxi-
mal apical dendritic segments as previously described (Pologruto
et al., 2004; Mao et al., 2008; Tian et al., 2009; Yamada et al., 2011),
yet the future experiments should be preferably performed at the
soma, where most in vivomulti-cell imaging are performed. Since
AP-associated Ca2+ transients are generally smaller in the soma
than in the proximal apical dendrites (Schiller et al., 1995), the
apparent performance of GECIs would be expected to be lower,
presumably making the criteria for GECI selection even more
stringent.
COMPARISON WITH PREVIOUS STUDIES USING THE SAME GECIs
Like many other variants of GCaMP generated by other groups
(Souslova et al., 2007; Muto et al., 2011), the relationship between
fluorescent responses of GECOs and the number of APs was
poorly characterized in the original study, where it was claimed
that GECOs showed larger dynamic range compared to GCaMP3
(Zhao et al., 2011). The source of inconsistencies between the
original results and ours is currently unknown, yet they might be
attributed to the difference in preparation (culture in the original
study vs. acute slice in ours) as well as whether or not imaging
was accompanied with electrophysiology. Given that GCaMP3
showed much larger single AP responses in culture (F/F0:
46 ± 4.2%) than in acute slice preparation (14 ± 2.7%) or in vivo
(7.9 ± 2.8%) (Tian et al., 2009), we believe that the experimen-
tal design used here should be better suited to assess the actual
performance of GECIs in mammalian neurons.
IMPLICATIONS FOR FUTURE IMPROVEMENT OF GCaMP AND OTHER
GECIs
As indicated from the comparison with OGB-1, one of the obvi-
ous goals for the next generation of GCaMP is reliable detection
of single APs. For successful improvement, appropriate guide-
lines for evaluating the efficacy of GECIs should be established
and accepted in the research community (Hires et al., 2008).
We propose that the following implications drawn from our
study should be taken into consideration: (1) Properties of GECIs
(dynamic range, affinity, kinetics, etc.) measured with purified
protein often show limited correlation with the performance
in neurons (e.g., Purified protein of GEM-GECO1 has a larger
dynamic range and a higher affinity compared to GCaMP3, but
performs far worse in neurons; see similar reports in Hendel
et al., 2008); (2) Screening of optimal GECIs for mammalian
neurons should be finalized with combined imaging and elec-
trophysiology in a non-culture system; and (3) GECI perfor-
mance can be strikingly different from one species to another
(e.g., GEM-GECO1 showed limited responsiveness in mouse
cortical neurons, but good functionality in C. elegans sensory
neurons).
We also propose that factors responsible for the reduced GECI
performance in mammalian neurons in physiological prepara-
tions should be identified and overcome; these might include
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interaction of GECIs with endogenous CaM (Miyawaki et al.,
1999; Palmer et al., 2006) or with other as yet unknown binding
proteins, or direct modifications of GECI protein such as phos-
phorylation. Some useful clues might be obtained by biochemical
comparison of cell lysates containing GECI protein from different
cell types (e.g., HeLa cells, where GECOs show high perfor-
mance vs. cortical pyramidal cells, where GECOs show reduced
performance) or from the same type of neurons in different
preparations.
We hope that our findings will alert the research com-
munity to the limitations of current GECIs, stimulate future
development and screening of a “holy-grail” GECI with
high sensitivity and fast kinetics, and facilitate appropri-
ate selection of optimal GECIs for different experimental
requirements.
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